GAIA

Our goal is to develop clinically validated digital therapeutics that provide patients, payers and doctors with effective products approved by the BfArM/FDA that have the same effect as medicines. Our products are developed by a multidisciplinary team of experts covering all the competencies needed to develop, launch and maintain first-class products for the most important markets. Our team consists of experienced doctors and psychotherapists, clinical scientists with experience in conducting phase II and phase III trials, IT and software engineers, regulatory affairs experts and market access specialists.